MERLINI, Luciano
 Distribuzione geografica
Continente #
NA - Nord America 2.135
EU - Europa 756
AS - Asia 358
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.251
Nazione #
US - Stati Uniti d'America 2.128
PL - Polonia 250
CN - Cina 185
DE - Germania 134
UA - Ucraina 107
SG - Singapore 74
GB - Regno Unito 73
IT - Italia 73
TR - Turchia 73
FI - Finlandia 34
SE - Svezia 34
BE - Belgio 21
ID - Indonesia 15
RU - Federazione Russa 12
CZ - Repubblica Ceca 7
CA - Canada 6
VN - Vietnam 4
ES - Italia 3
IN - India 3
IR - Iran 3
LT - Lituania 3
NL - Olanda 3
FR - Francia 2
BR - Brasile 1
EU - Europa 1
JO - Giordania 1
PA - Panama 1
Totale 3.251
Città #
Fairfield 310
Woodbridge 281
Warsaw 250
Ann Arbor 185
Chandler 175
Ashburn 153
Houston 134
Seattle 124
Jacksonville 123
Cambridge 98
Wilmington 89
Singapore 52
Beijing 51
Izmir 48
Munich 30
Nanjing 29
Princeton 28
Milan 26
Boardman 24
San Diego 24
New York 23
Bremen 22
Shanghai 22
Brussels 19
Ferrara 18
Jakarta 14
Shenyang 13
Dearborn 11
Helsinki 11
Los Angeles 10
Nanchang 10
Falls Church 9
London 8
Tianjin 8
Washington 8
Brno 7
Hebei 6
San Mateo 6
Santa Clara 6
Changsha 5
Kunming 5
Norwalk 5
Auburn Hills 4
Bologna 4
Des Moines 4
Jiaxing 4
Jinan 4
Addison 3
Dong Ket 3
Frankfurt am Main 3
Hangzhou 3
Lanzhou 3
Leawood 3
Mountain View 3
Ningbo 3
Redwood City 3
Toronto 3
Zhengzhou 3
Ardabil 2
Augusta 2
Borgo Val di Taro 2
Brescia 2
Chicago 2
Hasselt 2
Hefei 2
Hounslow 2
Monmouth Junction 2
Ottawa 2
Palm Bay 2
Philadelphia 2
Phoenix 2
Prescot 2
Taizhou 2
Varazze 2
Alpedrete 1
Amman 1
Antalya 1
Ceregnano 1
Changchun 1
Danyang 1
Ferrara di Monte Baldo 1
Fuzhou 1
Groningen 1
Guangzhou 1
Guarda Veneta 1
Hanoi 1
Irkutsk 1
Kilburn 1
Madrid 1
Montreal 1
New Bedfont 1
Orange 1
Panama City 1
Rueil-Malmaison 1
Saint Petersburg 1
Southwark 1
São Paulo 1
Trebaseleghe 1
Wandsworth 1
Totale 2.590
Nome #
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 330
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 195
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 155
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 148
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 146
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 146
Exon skipping-mediated dystrophin reading frame restoration for small mutations 144
Paternal germline mosaicism in collagen VI related myopathies 138
Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins 128
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 127
Autosomal recessive myosclerosis myopathy is a collagen VI disorder 125
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 124
Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies 119
Androgen receptor gene (CAG)n repeat analysis in the differential diagnosis between Kennedy disease and other motoneuron disorders. 119
Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy 115
Defective collagen VI α6 chain expression in the skeletal muscle of patients with collagen VI-related myopathies. 115
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 115
Autosomal recessive Bethlem myopathy 114
Early corticosteroid treatment in 4 duchenne muscular dystrophy patients: 14-year follow-up 114
Transcriptional behavior of DMD gene duplications in DMD/BMD males 112
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 107
null 99
Correlazione morfo-funzionale del coinvolgimento muscolare in pazienti con Malattia di Pompe late-onset 89
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 86
Genomic and transcription studies as diagnostic tools for a prenatal detection of X-linked dilated cardiomyopathy due to a dystrophin gene mutation. 27
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 26
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 20
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 16
Totale 3.299
Categoria #
all - tutte 13.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020503 0 0 0 0 60 87 69 82 66 74 44 21
2020/2021431 41 40 18 56 37 38 17 48 11 48 56 21
2021/2022362 10 35 31 5 10 15 43 16 11 21 52 113
2022/2023408 29 51 2 60 95 39 28 29 38 4 20 13
2023/2024229 15 35 24 3 24 52 5 13 1 1 2 54
2024/2025165 19 19 63 53 11 0 0 0 0 0 0 0
Totale 3.299